Member Info for Mars1

Huewai contract just been approved will help China relations

My guess and only a guess Dan said hopeful for CNY was the then problem in China had been resolved. However if I was running a business in China today my sole priority would be looking after my workforce and making sure communication was happening while this virus was occurring. It will be disaster recovery mode out there atm

It is likely John Lidgey’s NED appointment was part of the reverse takeover deal ie I would like to stay. Tapolczay is the ‘senior’ as he was allocated larger holding at the takeover so it is likely just showing respect to JL. It is also usual for the Chair to be responsible for the NEDS showing independence to the CEO who is responsible for day to day running. So nothing unusual in the Chair signing off the RNS. What is unusual is the very upbeat reference to news that is coming.

Exciting opportunities and trajectory not mincing his words

Will be the largest pharma market in the world in the not too distant future. Dan has already commented on this in vmarket Q&A said they had not provided any IP and the long term relationship was sound the delay was due to other issues that NSB/Yatai had with their authorities.

Saw this message today on a mug. “Be yourself unless you are a unicorn. If you are a unicorn be a unicorn”

Goup I can only do it from memory do not have access to history i looked at it at the time but not to worry if it was a sell price is up therefore buying has it, and less to be sold in the near future. Plenty of buyers today, and another closer to the forthcoming news.

Goup, funny I thought that was a buy. Spread at close was 8 to 8.30 and price went up this am

At least one thing to consider if the new China deal includes a JV then that will take some detailed work on the agreement. Loads of news incoming over the next few months all with added value.

This may step things up a gear

Yes have to be patient over pregnant pauses

Only 9 weeks to end Qtr1 will be expensive to get back in by then looking forward to 6 nations

Ps referring to Asian cities

Suppose to start with I better say thank you just in case, bbc news just gave me a general prod thinking respiratory issues are just going to continue to grow especially in the highly populated cities and it appears that both 2 and 4 are aligned although specialised. A more general respiratory inhaler against general infection may sell like hot cakes but like the marketable cannabinoids that are not of medical quality.

The market is huge the therapeutic benefit for pain relief for chronic illness and addiction relief to other drugs is globally massive can be much bigger than NXP002 but you can then add in the comfort products that calm and are feel good for the general therapeutic market this is not a small market

I seem to recall from the warrant note provided by Aim4 it said the company would do its utmost to find a buyer as they were Shakespeare something options (charity?). Maybe a buyer has been found for settlement 16th prior to next bit of news.

PS Esbriet sales may be £1bn+ But that is only a portion of the IPF market which is currently £5bn per annum

Chinson interested in the risk of new drugs outrunning NXP002 , yes it could happen but ‘new’ drugs takes years to develop, we see Hoffman has bought a drug in phase 2 (will complete end of this
year) then phase 3 (at least 18 months more likely longer) then regulatory approval (more years) value nearly £2bn.
So NFX value is nxp001,NXP002, Ebers, nxp004 value will come with deals as will cash as will a great time

Only one clinical trial left to do. If the first deal is with Kissei it will speed delivery to market as they have all the approval evidence for Tranilast. 6 months to complete trial from team appointment, are they in place? It is the responsibility of the counter party to get the drug to market. Japanese are efficient

Esbriet has annual revenue of over £1bn per annum and NXP002 has outperformed it in the first clinical tests. Take any fraction of 20% royalties and a p/e 20 and the number does not end in million